Pune, India, June 14, 2021 (GLOBE NEWSWIRE) -- Global Immunology Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The global immunology market size is expected to showcase exponential growth by reaching USD 158.69 billion by 2028 while exhibiting a CAGR of 8.1% between 2021 and 2028. Fortune Business Insights in its report, titled “Immunology Market, 2021-2028.”, mentions that the market stood at USD 85.74 billion in 2020. Factors such as the increasing demand for biosimilars worldwide will boost the demand for the product during the forecast period.
Global Immunology Market Highlights:
The Immunology Market report offers an in-depth analysis of the Active Pharmaceutical Ingredient industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Immunology Market concentration, and maturity analysis is elaborated in this report.
Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657
What does the Report Include?
The market report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to announce partnerships, introduce new products, and collaboration that will further contribute to the growth of the market between 2021 and 2028. Moreover, the research analyst has adopted several research methodologies to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
List of the Companies Profiled in the Global Market:
- Pfizer Inc. (New York, U.S.)
- F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
- AbbVie, Inc. (North Chicago, U.S.)
- Bristol-Myers Squibb Company (New York City, U.S.)
- Merck Sharp & Dohme Corp. (New Jersey, U.S.)
- Novartis AG (Basel, Switzerland)
- Janssen Global Services, LLC (Raritan, New Jersey, U.S.)
- Amgen Inc. (California, U.S.)
- Astellas Pharma Inc. (Tokyo, Japan)
- UCB SA (Brussels, Belgium)
- Eli Lilly and Company (Indianapolis, U.S.)
- Other Prominent Players
The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Immunology Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.
This report focuses on Active Pharmaceutical Ingredient Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The negative effect of the global pandemic, COVID-19, has been felt across several economies facing unprecedented loss. Owing to the lockdown announced by the government agencies, several industries have been at a standstill with limited operational activities. However, a collective effort from the government and the industries is likely to bring the economy back on track and aid in the resumption of industrial activities.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/immunology-market-100657
Market Segmentation:
On the basis of drug class, the market is segregated into monoclonal antibody (mAb), fusion proteins, immunosuppressants, polyclonal antibody (pAb), and others.
- Based on drug class, the monoclonal antibody (mAb) held a global immunology market share of about 64.5% in 2020 and is expected to dominate in the forthcoming years. This dominance is attributable to the increasing number of approvals for mAb by the government bodies to treat chronic ailments globally.
Based on disease indication, the market is classified into rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, inflammatory bowel disease, prophylaxis of organ rejection, and others. Moreover, on the basis of the distribution channel, the market is trifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. Lastly, based on region, the market is categorized into North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa.
Quick Buy - Immunology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100657
DRIVING FACTORS
Increasing Adoption of Biosimilars to Aid Growth
In February 2021, Sandoz Canada introduced adalimumab (HUMIRA) biosimilar, Hyrimoz, in Canada. The company informs that the drug has received approval and provides high efficacy in treating autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, adult Crohn’s disease, and adult uveitis, among others. The rising number of successful clinical trials is driving the demand for biological drugs leading several companies to invest in R&D to develop biosimilars, an affordable and effective imitation of the biological drugs. Therefore, the increasing demand for such products is expected to favor the global immunology market growth during the forecast period.
REGIONAL INSIGHTS
North America - North America stood at USD 46.17 billion in 2020 and is likely to hold the highest position in the market during the forecast period. This is due to the increasing prevalence of chronic ailments and the higher diagnosis rate of the patients that will boost the adoption of advanced immunology drugs in the region.
Europe – The market in the region is expected to experience considerable growth backed by the increasing prevalence of chronic disorders such as rheumatoid arthritis that propels the demand for effective immunology therapies and drugs in the region between 2021 and 2028. For instance, according to the British Society for Immunology, around 400,000 people in the U.K. suffered from rheumatoid arthritis in 2018.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunology-market-100657
COMPETITIVE LANDSCAPE
Key Players Adopt Strategies Such as Merger and Acquisition to Brighten Their Market Prospects
The market is witnessing massive competition among the players that are highly focused on strengthening the footprint. These players are acquiring other smaller enterprises to expand their immunology drugs portfolio and further boost sales revenue. Furthermore, the other key companies are leveraging the opportunities provided by the market by adopting proactive organic and inorganic strategies that will aid in maintaining their presence in the forthcoming years.
Industry Development:
- May 2020 - AbbVie, Inc. announced the acquisition of Allergan Plc with an aim to expand its presence and strengthen its position in the pharmaceuticals sector across the globe.
Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Autoimmune and Immunological Disorders by Key Countries
- Overview of Regulatory Scenario by Key Regions
- Key Industry Developments
- Overview of Current Advances in R&D for Immunology
- Global Immunology Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Monoclonal Antibody (mAb)
- Fusion Proteins
- Immunosuppressants
- Polyclonal Antibody (pAb)
- Others
- Market Analysis, Insights and Forecast – By Disease Indication
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Plaque Psoriasis
- Ankylosing Spondylitis
- Inflammatory Bowel Disease
- Prophylaxis of Organ Rejection
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Continued...
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/immunology-market-100657
Have a Look at Related Reports:
Ophthalmic Lasers Market Size, Share and Industry Analysis By Type (Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, Diode Lasers), Technology (Photodisruption, Selective Laser Trabeculoplasty, Photocoagulation), Application (Cataract Treatment, Glaucoma Treatment, Refractive Errors Treatment), End-User (Ophthalmic Laser Centers,Hospitals ) & Regional Forecast, 2019 – 2026
Trauma Implants Market Size, Share & Industry Analysis, By Product (Metal Plates & Screws, Pins/Wires, Nails & Rods, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026
Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026
Neuromodulation Devices Market Size, Share & Industry Analysis, By Product Type (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Transcranial Magnetic Stimulators (TMS)), By Type (Invasive, and Non-invasive), By Application (Pain Management, Neurological Disorders, Respiratory Disorders), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026
Population Health Management (PHM) Market Size, Share & Industry Analysis, By Component (Software, and Services), By Platform (Cloud-based, and On-premise), By End User (Healthcare Providers, Healthcare Payers, and Others), and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Press Release: https://www.fortunebusinessinsights.com/press-release/immunology-market-9140